[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5314 Introduced in House (IH)]

<DOC>






114th CONGRESS
  2d Session
                                H. R. 5314

   To provide for the development and dissemination of programs and 
materials for training pharmacists, health care providers, and patients 
  on the circumstances under which a pharmacist may decline to fill a 
prescription for a controlled substance because the pharmacist suspects 
  the prescription is fraudulent, forged, or otherwise indicative of 
              abuse or diversion, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 24, 2016

 Mr. DeSaulnier (for himself and Mr. Carter of Georgia) introduced the 
   following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
   To provide for the development and dissemination of programs and 
materials for training pharmacists, health care providers, and patients 
  on the circumstances under which a pharmacist may decline to fill a 
prescription for a controlled substance because the pharmacist suspects 
  the prescription is fraudulent, forged, or otherwise indicative of 
              abuse or diversion, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Empowering Pharmacists in the Fight 
Against Opioid Abuse Act''.

SEC. 2. PROGRAMS AND MATERIALS FOR TRAINING ON CERTAIN CIRCUMSTANCES 
              UNDER WHICH A PHARMACIST MAY DECLINE TO FILL A 
              PRESCRIPTION.

    (a) In General.--Not later than 1 year after the date of enactment 
of this Act, the Administrator of the Drug Enforcement Administration, 
in consultation with the Secretary of Health and Human Services and the 
Commissioner of Food and Drugs, shall develop and disseminate programs 
and materials for training pharmacists, health care providers, and 
patients on--
            (1) circumstances under which a pharmacist may, consistent 
        with section 201 of the Controlled Substances Act (21 U.S.C. 
        801 et seq.) and regulations thereunder, including section 
        1306.04 of title 21, Code of Federal Regulations, decline to 
        fill a prescription for a controlled substance because the 
        pharmacist suspects the prescription is fraudulent, forged, or 
        otherwise indicative of abuse or diversion; and
            (2) any Federal requirements pertaining to declining to 
        fill a prescription under such circumstances.
    (b) Stakeholder Input.--In developing the programs and materials 
required by paragraph (1), the Administrator of the Drug Enforcement 
Administration shall seek input from relevant national, State, and 
local associations, boards of pharmacy, medical societies, and 
licensing boards.
                                 <all>